000739:SHE
Apeloa Pharmaceutical Co Ltd
CNÂ¥23.42
arrow_downward
-1.64%(-0.39) 1D
Oct 16, 3:04:48 PM GMT+8 · CNY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 000739...
Open
CNÂ¥24.04
High
CNÂ¥24.76
Low
CNÂ¥23.09
Mkt. cap
27.13B
Avg. vol.
16.27M
Volume
15.09M
Dividend
1.61%
Quarterly dividend
CNÂ¥0.09
Ex-dividend date
Oct 8, 2026
P/E ratio
31.78
52-wk high
CNÂ¥28.50
52-wk low
CNÂ¥14.89
EPS
CNÂ¥0.74
Shares outstanding
1.16B
No. of employees
7K
Open
CNÂ¥24.04
High
CNÂ¥24.76
Low
CNÂ¥23.09
Mkt. cap
27.13B
Avg. vol.
16.27M
Volume
15.09M
Dividend
1.61%
Quarterly dividend
CNÂ¥0.09
Ex-dividend date
Oct 8, 2026
P/E ratio
31.78
52-wk high
CNÂ¥28.50
52-wk low
CNÂ¥14.89
EPS
CNÂ¥0.74
Shares outstanding
1.16B
No. of employees
7K
News stories
From web sources and news partners
The Motley Fool
·
19 minutes ago
Should You Invest in the S&P 500 Right Now or Wait? There's 1 Clear Answer
Pluang
·
5 minutes ago
VIX jumps 21.45% as S&P 500 falls 1.1%, Bitcoin stays above $80K
Yahoo Finance UK
·
3 hours ago
Yardeni Lowers S&P 500 Target to 7,900 Despite Maintaining 2027 Earnings Forecast
MarketWatch
·
3 hours ago
These surprising stocks could be some of the biggest drivers of S&P 500 earnings growth
Profile
Apeloa Pharmaceutical Co., Ltd., known as Apeloa, is a Chinese pharmaceutical manufacturer under Hengdian Group. The company is headquartered in Hengdian, Dongyang, Zhejiang, China. It was founded in 1989 and has been listed on the Shenzhen Stock Exchange since 9 May 1997. Apeloa provides contract development and manufacturing services and manufactures APIs and finished dosage forms; products span cardiovascular, anti-infective, psychiatric and oncology areas.
Apeloa has 7400 employees, 8 manufacturing sites and 3 R&D centers in Boston, Shanghai and Hengdian, covering flow chemistry, synthetic biology and biocatalysis, and peptide development. It has invested over USD20 million in flow chemistry over the past ten years in an effort to advance sustainable pharmaceutical manufacturing. In Boston, its 17,000-square-foot facility does R&D related to chemistry needs in drug development, including preclinical chemistry, scale-up production and new drug development.
Apeloa Pharmaceutical has successfully passed 20 U.S. FDA inspections since 2006. Wikipedia
About Apeloa Pharmaceutical Co Ltd